Tokushima, Japan

Takeshi Nikawa

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Nikawa. Retrieved from https://idiyas.com/inventor/takeshi-nikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takeshi Nikawa

Introduction

Takeshi Nikawa is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of muscular health. His innovative work has led to the development of a unique composition aimed at suppressing muscular atrophy.

Latest Patents

Takeshi Nikawa holds a patent for a composition designed to suppress muscular atrophy. This composition includes as active ingredients one or more peptides selected from a specific group, including tripeptides such as DIY, IYN, YNP, NPQ, DFY, DIF, FYN, IFN, FNP, and NPK. Additionally, it comprises dipeptides that include F, as well as dipeptides DI, IY, YN, and NP. This patent represents a significant advancement in the treatment of muscular atrophy.

Career Highlights

Takeshi Nikawa is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the field of pharmaceuticals. His work at Otsuka has allowed him to collaborate with other talented professionals and further his research in muscular health.

Collaborations

Some of his notable coworkers include Ayako Maita and Muneshige Shimizu. Their collaboration has fostered a productive environment for research and development within the company.

Conclusion

Takeshi Nikawa's contributions to the field of biotechnology, particularly through his patent for a composition that suppresses muscular atrophy, highlight his innovative spirit and dedication to improving health outcomes. His work at Otsuka Pharmaceutical Company, Limited, alongside talented colleagues, continues to pave the way for advancements in muscular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…